Chromium supplementation in polycystic ovarian syndrome cases.

Effect of chromium supplementation on insulin resistance and weight reduction in polycystic ovarian syndrome cases.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201506001153655

Enrollment

100

Registered

2015-05-30

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth polycystic ovary syndrome patients

Interventions

Chromium group

Controls

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Body mass index between 30kg /m2 and 34.5 kg/m2 -12 or more small follicles should be seen in an ovary on ultrasound examination oriented in the periphery, giving the appearance of a 'string of pearls'. - Increased size of the ovaries, that is, 1.5 to 3 times larger than normal.

Exclusion criteria

Exclusion criteria: Women with Polycystic ovarian syndrome and on diet or using metformin

Design outcomes

Primary

Measure	Time frame
Insulin resistance;Follicular growth maturation	—

Secondary

Measure	Time frame
Body mass index (BMI)	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com002-01223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026